Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccination.

Using this assay, we explored the dynamics of antibody responses to Mpox vaccination and infection over time and demonstrated that circulating antibodies post MVA-vaccination are significantly lower than post infection and wane considerably significantly over time.

also in 27 other papers